Price (delayed)
$10.93
Market cap
$497.8M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.15
Enterprise value
$544.7M
Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore
There are no recent dividends present for AXGN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.